InMed Pharmaceuticals Inc. Annual Return On Equity in % from 2020 to 2023

Taxonomy & unit
ratio: %
Description
Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Summary
InMed Pharmaceuticals Inc. quarterly/annual Return On Equity history and growth rate from 2020 to 2023.
  • InMed Pharmaceuticals Inc. Return On Equity for the quarter ending December 31, 2023 was -91.8 %, a 38.7% increase year-over-year.
  • InMed Pharmaceuticals Inc. annual Return On Equity for 2023 was -63.8 %, a 57.7% increase from 2022.
  • InMed Pharmaceuticals Inc. annual Return On Equity for 2022 was -151 %, a 10.4% decline from 2021.
  • InMed Pharmaceuticals Inc. annual Return On Equity for 2021 was -137 %, a 30% decline from 2020.
Return On Equity, Annual (%)
Return On Equity, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date
2023 -63.8 +86.9 +57.7% Jul 1, 2022 Jun 30, 2023
2022 -151 -14.1 -10.4% Jul 1, 2021 Jun 30, 2022
2021 -137 -31.5 -30% Jul 1, 2020 Jun 30, 2021
2020 -105 Jul 1, 2019 Jun 30, 2020
* An asterisk sign (*) next to the value indicates that the value is likely invalid.